Purpose: Transurethral resection, chemotherapy and radiation with salvage cystectomy may be used as alternatives to immediate radical cystectomy in the management of invasive bladder cancer. Concern exists about the function of the retained bladder after such therapy.
Organ conservation has been judged an effective and desirable alternative to radical surgery for many cancers, most notably breast, anus and larynx. Good functional or cosmetic results have been obtained at these sites without compromising survival. [1] [2] [3] Organ conservation in muscle invading bladder cancer has been a more contentious issue. 4, 5 Several groups using the combination of radiation with cisplatin based chemotherapy and an aggressive transurethral resection of the tumor (TURBT) have documented high rates of local control and cure. 4, 6 -8 Despite these satisfactory cancer outcomes, concern remains among physicians about the long-term function of a conserved, irradiated bladder, the collateral consequences for bowel and, in men, erectile function. The major series report low rates of post-chemoradiation cystectomy for hematuria or low capacity bladder (less than 1%) and 2 series suggest low levels of patient reported symptoms. 9, 10 However, the issue of bladder function has not been evaluated in a comprehensive fashion. This study redresses this deficiency in the bladder sparing literature. We asked long-term survivors from our 1986 to 2000 protocols to return for a formal urodynamic evaluation and to complete a validated quality of life questionnaire.
MATERIALS AND METHODS
Patient population. Between 1986 and 2000, 197 patients with invasive bladder cancer (clinical stages T2-4a) were entered on 5 successive prospective protocols using TURBT, chemotherapy, and radiation. 4, 7, 8, 11, 12 An additional 24 with T2-4a tumors and good medical status were treated with TURBT and chemoradiation but off protocol because of specific exclusions such as a language barrier or another recent malignancy.
Protocol designs. All protocols selected patients for bladder conservation on the basis of initial response to trimodality therapy (TMT). Bladder conservation was reserved for those who had a complete clinical response when evaluated at a midpoint in therapy. These patients, approximately two thirds of the total, then received further chemotherapy and radiation to a total tumor dose of 64 to 65 Gy. Patients whose invasive tumors persisted or recurred were advised to undergo salvage cystectomy. In these phase II and III protocols different schedules of radiation or drugs were tested. 4, 8, 11, 12 All patients received cisplatin, 98 methotrexate and vinblastine, 29, 5-fluouracil, and 29 received twice a day radiation.
Patients recalled for study. The fate of the bladders of the 221 patients treated from 1986 to 2000 is shown in the figure. A total of 62 had incomplete responses to induction therapy and were encouraged to undergo cystectomy, though 17 re-fused or had become medically unfit. Of the 159 complete responders 25 subsequently underwent cystectomy for invasive or multiple superficial recurrences. Of the 151 patients not treated with cystectomy 39 died of metastatic disease and 38 of other medical conditions. Three are alive but have metastatic disease at the time of this study. A total of 71 potential participants were left for the current study. Of these, 32 returned for urodynamic study (UDS) (45%) and 48 completed questionnaires (68%).
Median patient age at original treatment was 62.1 years (range 49 to 80). Median followup from original treatment to the current study was 6.3 years (range 1.6 to 14.9). A record was kept of the reasons given by patients who declined to participate in the study.
Urodynamic evaluation. A uroflow study provided the voiding pattern, voided volume, and maximum and average urinary flow rates. Post-void residual volume was obtained by catheter before cystometry. A rectal catheter measured abdominal pressure. A cystometrogram (CMG) was performed as well as video urodynamics. The volume at first sensation, volume at first and maximal urge, bladder compliance during filling and the presence or absence of involuntary contractions were recorded. CMG results determined the extent to which bladder function was preserved. A pressure flow study determined maximum detrusor pressure and flow during voiding. Cystourethrography determined bladder contour and, in women, the presence of stress incontinence and/or prolapse.
Quality of life evaluation. Self-administered questionnaires were given. No published English language survey instrument directly addresses the quality of life of patients with bladder cancer treated with organ conservation. Therefore, we used items from scales validated in patients with prostate cancer 13 and adapted additional items assessing long-term complications of pelvic radiation therapy. 14, 15 We assessed sexual function in men with items from our prostate cancer instrument 13 and in women with the 9 items from the Brief Index of Sexual Functioning for Women. Global health related functional status and well-being were assessed with the general health perceptions and physical functioning scales of the Medical Outcomes Study Short Form Health Survey (SF-36). 16 Measures of body awareness were also used. 17, 18 
RESULTS
Responses. During the study period (from March 2001 to May 2002) there were 71 potentially available patients alive and with their native bladders (see figure). Of these patients 49 (69%) participated in some aspect of the study (table 1). A total of 31 patients came for a UDS and completed a questionnaire, 17 completed a questionnaire alone and 1 presented for only the UDS. Those only answering the questionnaire or not participating at all gave reasons which are summarized in table 2. The most common reasons were distance, other active medical problems and fear of a catheter. Three who lived abroad or entered nursing homes could not be contacted. Those who did not participate in the study were no more likely to have had bacillus Calmette-Guerin (BCG) or to have had more than 3 TURBTs, factors which might be Flow diagram illustrating outcome for all 221 patients treated with trimodality therapy and illustrating source of 71 invited to participate in current study. Asterisk indicates dead from bladder cancer or intercurrent disease. expected to predict a worse functional outcome. Nonparticipants were significantly older at the time of study (76.5 vs 67.9 years). Those consenting to the UDS were more likely to live in Massachusetts than those who consented only to a questionnaire (75% vs 53%). Urodynamic studies. Median age of the studied females was 67 years and the males 72. The UDS was performed a median of 7.0 years after chemoradiation. One patient was currently using finasteride and 4 diuretics. None were using either ␣-blocker or anticholinergic medication. After urodynamic and clinical evaluation 24 of 32 patients were judged to have normally functioning bladders. Although some of the 24 normal patients had one or another abnormal urodynamic parameter the overall diagnostic impression was that of a normally functioning bladder. Details of the UDS are shown in table 3.
Uroflow: Median voided volume was 284 cc with a range of 125 to 630 cc. Of the 18 males with uroflow data, 5 ages 51, 66, 72, 77 and 85 had a maximum urine flow rate (Qmax) less than 15 ml per second, the lower limit of normal in men. The post-void residual was 100 cc or greater in 3 patients, 2 with urodynamic evidence of bladder outlet obstruction. Of the 10 females 2 were unable to void for the uroflow study. All others had a Qmax greater than 15 ml per second with a median of 21.6. One had a post-void residual greater than 100 cc without evidence of functional abnormality on further testing.
Cystometrogram: Males had first sensation with 55 to 317 cc fluid in the bladder, a resting intravesical pressure of 1 to 7 cm H 2 O (median 2) and a capacity of 221 to 747 cc (median 400) without evidence of involuntary contractions. Compliance was impaired in 5, 3 of whom had bladder outlet obstruction on pressure flow study, and 1 who required BCG and further resection for tumor recurrence, both possible contributing factors. In spite of the impaired compliance, the bladders had good storage and voiding function by urodynamics. Two of the females had impaired compliance, hyper-
Pressure Flow Study: Of the 15 men who were able to void for the pressure flow study 8 had a sustained detrusor pressure greater than 40 cm H 2 O and a flow rate less than 12 ml per second. Of the 8 women completing the pressure flow study 1 had a voiding pressure greater than 100 cm H 2 O with a flow rate of 4 ml per second.
Video Study: In male patients with pressure flow studies suggesting bladder outlet obstruction, 3 had an impression of a median lobe on video study. Unilateral reflux was demonstrated in 3 males, diverticuli in 1 and trabeculi in 1. An incontinent woman had a cystocele with pelvic floor prolapse.
Quality of life questionnaire. Urinary Function: Urinary symptoms reflected gender differences found in the general population. Women reported urinary incontinence and difficulty controlling urine more often, while men more often reported symptoms of obstruction/irritation (tables 4 and 5). A fifth of patients reported some degree of incontinence within the preceding 7 days, with incontinence more than twice as frequent in women. None reported dysuria. Hematuria was reported by 5 patients during the preceding 6 months. Distress levels reported by men and women were less than the objective reporting of symptoms. No patient reported even moderate distress regarding urgency or leaking. The questionnaire responses of the 7 with decreased bladder compliance by UDS were studied. There was no leakage of urine in 5 and only 1 reported slight distress from symptoms. These 7 were no more likely than the remaining patients to have had 3 or more TURBTs or BCG.
Bowel Function: Bowel symptoms were evident in some patients. Difficulty in bowel control at any time in the last week was reported in 7 men (20%) and 3 women (27%), and 6 men (17%) reported abdominal cramping or pain with bowel movements. On a grade scale of 1 to 5 those reporting these symptoms stated that they occurred at either a grade 2 or 3 level ("occasional" or "moderately/fairly frequently"). No patients reported that any of the itemized bowel symptoms occurred either "very frequently" or with a severity of "extremely".
Sexual Function: Only 2 women completed the sexual function items, so we report only male responses. Although 39% of men reported no erections in the last 4 weeks, 36% reported full erections and another 18% less firm erections, but sufficient for vaginal penetration. A total of 54% were capable of orgasm and 50% of ejaculation. Only 8% of men re- † Unaffected by bowel symptoms defined as no symptoms at all during the last week.
ported they were dissatisfied with their sex life while 59% were satisfied and 33% were neither satisfied nor dissatisfied. Sildenafil was used by 5 (16%).
Global Health related Quality of Life: Physical functioning was excellent in this group with an overall mean of 89. General health perceptions were lower with a mean of 74. Comparable means for men and women age 65 to 74 in the United States population are 69.4 for Physical Functioning and 62.6 for General Health Perceptions. 17 Body Awareness: The study population had high levels of awareness of internal body sensations as measured by the Body Awareness scale. The mean score was 58 with 30% of patients indicating a strong tendency to attend closely to body sensations. DISCUSSION Our evaluation shows that at a median of 6 years after TMT the majority of conserved bladders function normally. Evidence of prior irradiation was found in some and seen as decreased bladder compliance, detectable levels of urinary incontinence in women, and a greater than normal frequency of bowel urgency and control issues among both sexes. However, other urinary and bowel symptoms were uncommon and few patients reported significant levels of distress. Overall, the level of bladder, bowel and general functioning was acceptable for most patients. Although quality of life information had been previously obtained for patients undergoing bladder conserving therapy, to our knowledge this study is the first to capture urodynamic data in parallel. 9, 10 We were concerned about selection bias in our study population. The figure and table 2 trace the patients potentially available for this study and show that a high proportion did consent to return for a relatively unpleasant study that did not offer any obvious personal gain. In a comparable quality of life study on cystectomy only 61% gave consent for a questionnaire alone without any parallel invasive study. 18 Questionnaire studies from Italy and Sweden, again without UDS, have had response rates of 66% and 82%, respectively. Those not returning for UDS may have worse urinary function although high median age and current distant location make it more likely that practical considerations prevented participation.
The questionnaire results for urinary function reported in this study are similar to those recorded in the Italian and Swedish cross-sectional studies in which more than 74% of patients reported good urinary function. 9, 10 The urodynamic studies showed that the majority of patients were within the normal range. Less than a quarter of tested patients demonstrated decreased bladder compliance, a recognized consequence of radiation.
Pelvic radiation has recognized consequences for bowel and rectal function. In comparison with the cystectomy series these consequences represent an additional price that patients opting for bladder conservation have to pay. A total of 22% had some symptoms related to bowel urgency or control with 14% reporting moderate or greater distress. In the Swedish and Italian studies figures of 10% and 32% were reported for moderate or more severe symptoms. Both studies compared bowel function in patients treated with radiation with that seen in patients undergoing cystectomy. Bowel symptoms were greater for those receiving radiation than for those receiving cystectomy (10% vs 3% and 32% vs 24%, respectively) but in neither was this percentage statistically significant.
In the assessment of sexual function most women preferred not to answer the questions and therefore no data are available for them. However, almost all men did answer the questions. In contrast to patients we studied who have been irradiated for prostate cancer, the majority of patients with bladder sparing treatment reported adequate erectile function (full or sufficient for intercourse), and only 8% reported dissatisfaction with their sex lives. 19 These results appear better than those seen in the Swedish and Italian series in which 38% and 25% of men retained useful erections compared with 13% and 8% of cystectomy controls. Our series allowed the use of sildenafil, which probably contributed to the better outcome.
The symptoms recorded in our study had little apparent effect on overall physical function as measured by the Physical Functioning subscale of the SF-36. Scores on the General Health Perceptions scale of the SF-36 were higher than those of similar age adults, perhaps reflecting the performance status required to receive chemotherapy. The high scores on the Body Awareness scale, a marker of patient perceived need for physician attention, indicate that these patients with bladder cancer are highly attentive to bodily functions compared to a similar age health maintenance organization population without cancer. 17 We speculate that the combination of modest urinary and bowel symptoms, and alertness to signs of cancer recurrence contribute to this result. Thus, while symptoms attributable to pelvic irradiation are evident in this population, the level of function appears acceptable to most patients.
CONCLUSIONS
This study used patient self-reporting and a urodynamic evaluation to assess the long-term consequences of bladder conservation with transurethral resection, chemotherapy and radiation. Normal bladder function was preserved in the majority of patients with low levels of symptom related distress. Approximately 1 in 5 reported persistent bowel symptoms.
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